Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Dengue virus can infect human hair follicle cells and may cause hair loss.

A teenager had both alopecia areata and vitiligo, which are rare to occur together.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Both mouse and rat models are effective for testing alopecia areata treatments.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.

Mycophenolate helps reverse hair loss effects caused by IFN-γ by activating a key hair growth pathway.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

The meeting presented new findings on hair stem cells, pigmentation, genetics, and modern hair treatment techniques.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Compartmentalized organization might be crucial for stem cells to effectively respond to growth or injury.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Minoxidil improves blood flow and vessel flexibility, potentially helping with vascular stiffness.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.